NCT05083936View on ClinicalTrials.gov

Prospective Comparison of 18F-FDG and 18F-FET PET for Response Evaluation in Patients With Primary Central Nervous System Lymphoma

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 27, 2021

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Patients With Suspected or Diagnosed Central Nervous System Lymphoma
Interventions
DRUG

[18F]FET

Imaging evaluation using LAT1/4F2hc substrate overexpressed in brain tumor

Trial Locations (1)

05505

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER